Cerus Corporation (CERS)
NASDAQ: CERS · Real-Time Price · USD
2.340
-0.170 (-6.77%)
At close: May 15, 2026, 4:00 PM EDT
2.330
-0.010 (-0.43%)
After-hours: May 15, 2026, 7:40 PM EDT
Cerus Revenue
Cerus had revenue of $59.89M in the quarter ending March 31, 2026, with 22.60% growth. This brings the company's revenue in the last twelve months to $244.84M, up 18.41% year-over-year. In the year 2025, Cerus had annual revenue of $233.80M with 16.13% growth.
Revenue (ttm)
$244.84M
Revenue Growth
+18.41%
P/S Ratio
2.17
Revenue / Employee
$787,473
Employees
275
Market Cap
468.86M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 233.80M | 32.48M | 16.13% |
| Dec 31, 2024 | 201.32M | 14.52M | 7.78% |
| Dec 31, 2023 | 186.80M | -1.52M | -0.81% |
| Dec 31, 2022 | 188.32M | 28.80M | 18.05% |
| Dec 31, 2021 | 159.52M | 45.27M | 39.62% |
| Dec 31, 2020 | 114.25M | 20.48M | 21.83% |
| Dec 31, 2019 | 93.77M | 17.72M | 23.30% |
| Dec 31, 2018 | 76.05M | 24.73M | 48.17% |
| Dec 31, 2017 | 51.33M | 12.05M | 30.68% |
| Dec 31, 2016 | 39.28M | 5.05M | 14.76% |
| Dec 31, 2015 | 34.22M | -2.19M | -6.02% |
| Dec 31, 2014 | 36.42M | -3.24M | -8.17% |
| Dec 31, 2013 | 39.66M | 2.87M | 7.80% |
| Dec 31, 2012 | 36.79M | 3.74M | 11.32% |
| Dec 31, 2011 | 33.04M | 9.94M | 42.99% |
| Dec 31, 2010 | 23.11M | 5.13M | 28.51% |
| Dec 31, 2009 | 17.98M | 1.48M | 8.94% |
| Dec 31, 2008 | 16.51M | 5.46M | 49.47% |
| Dec 31, 2007 | 11.04M | -19.27M | -63.56% |
| Dec 31, 2006 | 30.31M | 16.81M | 124.57% |
| Dec 31, 2005 | 13.50M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Varex Imaging | 857.50M |
| Orthofix Medical | 825.37M |
| Tactile Systems Technology | 343.52M |
| OrthoPediatrics | 243.30M |
| Cytek Biosciences | 204.17M |
| Beta Bionics | 110.24M |
| NeuroPace | 99.53M |
| Delcath Systems | 90.44M |
CERS News
- 10 days ago - Cerus management to meet with Craig-Hallum - TheFly
- 16 days ago - Cerus upgraded to Buy from Neutral at BTIG - TheFly
- 16 days ago - Cerus Earnings Call Transcript: Q1 2026 - Transcripts
- 16 days ago - Cerus reports Q1 EPS (1c), consensus (4c) - TheFly
- 16 days ago - Cerus raises FY26 product revenue view to $227M-$231M from $224M-$228M - TheFly
- 16 days ago - Cerus Corporation Announces First Quarter 2026 Financial Results - Business Wire
- 20 days ago - Cerus announces new, four-year supply agreement with EFS - TheFly
- 20 days ago - Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System - Business Wire